Professor | 马国 | 数字化转型顾问

Upload Avatar (500 x 500)

Name

马国

Contact Information

mg0328@126.com

Language ability

中文, 英语

Province

上海

University/Lab Affiliation and Title	复旦大学
Faculty	Pharmaceutical Sciences
Academic Background & Achievements	2004-2007 博士学位: 四川大学华西药学院 2001-2004 硕士学位: 国家药监局四川抗菌素工业研究所 1992-1996 学士学位: 山东医科大学药学院
Work Experience	2024-至今 - 复旦大学药学院 - 教授，博士生导师，硕士生导师 2014-2023 - 复旦大学药学院 - 副教授，硕士生导师，博士生导师 2010-2011 - 美国休斯顿大学药学院 - 访问学者 2007-2014 - 复旦大学药学院 - 讲师 1996-2001 - 山东省泰安市夏张医院 - 药剂师
Awards	2023: 港爱奖教金 2023: 复旦大学课程思政标杆课程 2023: 优秀导师奖，中国医药行业科技交流中心 2022: 上海市课程思政示范课程 2022: 上海市课程思政示范团队 2022: 复旦大学十佳教师团队——临床药学创新型教学团队 2022: 上海市优秀教学成果奖一等奖 2022: 复旦大学教材建设奖一等奖 2020: 一健康基金优秀教师三等奖 2018: 中华医学会医学教育研究立项课题一等奖

University/Lab Affiliation and Title

复旦大学

Faculty

Pharmaceutical Sciences

Academic Background & Achievements

Work Experience

Awards

Areas of Focus	基于AI、网络药理学、PK/PD和多组学整合的中药（降糖）作用机制与药效物质基础研究中西药ADME/Tox及其调控核受体、转运体和代谢酶介导的药物相互作用基于AI、循证药学与真实世界证据的药品临床综合评价
Publications	Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis, Yanan Ding, Yufei Shi, Ruifang Guan, Shiwei Yan, Haiyang Liu, Zihan Wang, Jiyifan Li, Tiandian Wang, Weimin Cai, Guo Ma, 2023 Prediction of pediatric dose of tirzepatide from the reference adult dose using physiologically based pharmacokinetic modelling, Ruifang Guan, Xuening Li, Guo Ma, 2023 Cardiovascular Benefits and Safety of Sotagliflozin in Type 2 Diabetes Mellitus Patients with Heart Failure or Cardiovascular Risk Factors: A Bayesian Network Meta-Analysis, Jiyifan Li, Chenyang Zhu, Jingru Liang, Jiarong Hu, Haiyang Liu, Zihan Wang, Ruifang Guan, Junwei Chow, Shiwei Yan, Longzhou Li, Fuyan Ma, Guo Ma, 2023 Efficacy and Safety of Teneligliptin in Patients with Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis, Miao Zhu, Ruifang Guan, Guo Ma, 2023 Effect of Astragali Radix Extract on Pharmacokinetic Behavior of Dapagliflozin in Healthy and Type 2 Diabetic Rat, Wandi Du, Jiarong Hu, Jingru Liang, Xiaolei Yang, Boyu Fan, Guo Ma, 2023

Areas of Focus

基于AI、网络药理学、PK/PD和多组学整合的中药（降糖）作用机制与药效物质基础研究
中西药ADME/Tox及其调控
核受体、转运体和代谢酶介导的药物相互作用
基于AI、循证药学与真实世界证据的药品临床综合评价

Publications

Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis, Yanan Ding, Yufei Shi, Ruifang Guan, Shiwei Yan, Haiyang Liu, Zihan Wang, Jiyifan Li, Tiandian Wang, Weimin Cai, Guo Ma, 2023
Prediction of pediatric dose of tirzepatide from the reference adult dose using physiologically based pharmacokinetic modelling, Ruifang Guan, Xuening Li, Guo Ma, 2023
Cardiovascular Benefits and Safety of Sotagliflozin in Type 2 Diabetes Mellitus Patients with Heart Failure or Cardiovascular Risk Factors: A Bayesian Network Meta-Analysis, Jiyifan Li, Chenyang Zhu, Jingru Liang, Jiarong Hu, Haiyang Liu, Zihan Wang, Ruifang Guan, Junwei Chow, Shiwei Yan, Longzhou Li, Fuyan Ma, Guo Ma, 2023
Efficacy and Safety of Teneligliptin in Patients with Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis, Miao Zhu, Ruifang Guan, Guo Ma, 2023
Effect of Astragali Radix Extract on Pharmacokinetic Behavior of Dapagliflozin in Healthy and Type 2 Diabetic Rat, Wandi Du, Jiarong Hu, Jingru Liang, Xiaolei Yang, Boyu Fan, Guo Ma, 2023

Ai 网络药理学 Pk/Pd 多组学中药降糖机制药效物质基础研究

汪亚勤 - 复旦大学

章蕴毅 - 复旦大学

Area of Focus
抗炎 | 免疫药理学 | 补体 | 免疫 | 药理学 | 中药 | 药效 | 安全性评价 | 临床研究 | 新药开发

朱海燕 - 复旦大学

View All

Personal Information